General MedicationsINJECTIONGeneric
AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AMIKACIN SULFATE
Standard Dose
EQ 10MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050618 (NDA).
Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor APOTHECON Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050618 (NDA). Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor APOTHECON Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.